A discrete choice experiment reveals treatment preferences in follicular lymphoma patients, suggesting better outcomes with preference integration.
PFS had the greatest impact on treatment selection among patients with R/R FL, followed by the impact of CRS on QoL and the mode of administration. Patients were willing to trade some efficacy for improved safety and convenience, while treatment duration had minimal influence. Incorporating patient preferences may improve adherence and outcomes and warrants further evaluation.
No takes yet. Share an insight, caveat, or question.
Gaballa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: